CRSP

CRISPR Therapeutics AG

Healthcare · Biotechnology

$245.51 sample

-2.37 (-0.96%) 1D

Market cap

$1.32T

Price as of

2026-10-15

Latest filing

8-K · 2026-10-09

Alerts

8

Price$245.51 +9.65% 3M daily closessample

254.32222.85

2026-07-202026-08-112026-09-022026-09-232026-10-15

purchase / approvalsale / rejectionfiling / neutral

Latest events

Filings, trades, FDA; newest first

Oct 09SEC10-Q filed
Oct 01INSInsider sell: Chief Financial Officer
Sep 22INSInsider buy: EVP, Operations
Sep 17SECDEF 14A filed
Sep 14INSInsider sell: Chief Financial Officer
Sep 08INSInsider sell: Director
Aug 31INSInsider sell: Director
Aug 20INSInsider sell: Chief Financial Officer

Sign up to see the real CRSP record →

Company facts

SEC EDGAR registration

Name: CRISPR Therapeutics AG
Sector: Healthcare
Industry: Biotechnology
Smart-money score: -18sample, -100 to +100
Reporting currency: USD

Who is positioning in CRSP

sample

Insiders: 20 insider transactions over 90 days, net selling, $890.3M
Congress: 1 members traded over 90 days
Institutions · 13F: 18 funds hold $19.5B
Activists · 13D/G: No 13D/13G activist filings on record

How are the fundamentals trending?

sample, by period end

Revenue$45.6B +14.8% y/y

Q4 2024Q3 2026

Inventory$28.2B +10.2% y/y

Q4 2024Q3 2026

Accounts receivable$20.5B +7.1% y/y

Q4 2024Q3 2026

Total debt$58.6B +14.3% y/y

Q4 2024Q3 2026

Peers

sample

Sample peer A: $1.09T -10.4% 3M
Sample peer B: $320.9B -3.0% 3M
Sample peer C: $630.8B +1.5% 3M
Sample peer D: $1.24T +11.2% 3M
Sample peer E: $336.8B +15.4% 3M